Sustainable Procurement & CSR News - Pharmaceutical Industry
24.5K views | +0 today
Follow
Sustainable Procurement & CSR News - Pharmaceutical Industry
Latest news related to sustainable supply chain in the health and pharmaceutical industry
Curated by EcoVadis
Your new post is loading...
Scooped by EcoVadis
July 21, 2021 6:55 AM
Scoop.it!

Trends that help in re-shaping the future of Pharmaceutical Supply Chain

Trends that help in re-shaping the future of Pharmaceutical Supply Chain | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it
The Pharmaceutical Supply Chain in 2021 will require Robust Solutions

Pharmaceutical SCM has become more unpredictable and basic in current digital world situation. It holds the life-saving guarantee of individuals and demands the participation of distinct partners. It includes pharma manufacturers, distributors, wholesalers, customers, and regulatory agencies. Notwithstanding COVID-19, supply chains have significantly been disrupted owing to nation-wide limitations all around the world. This supply chain disturbance has left challenges in the pharmaceutical industry, require to reexamine supply chain management and robust solution.

The challenges of increased market demand and stricter legislation increase the demand for more efficient, flexible, and specific Pharmaceutical SCM software. Today, Pharma distributors must have to move products to their customers an exact time or faster while maintaining lower inventory levels. Also, Meta-Pharma – Pharmaceutical ERP software helps to improve supply chain management, customer relations, vendor agreements, identification of slow-moving, and out-of-stock items, and inventory data.
No comment yet.
Scooped by EcoVadis
July 1, 2020 3:00 AM
Scoop.it!

eConsults: An essential piece of telehealth for chronic care management

eConsults: An essential piece of telehealth for chronic care management | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it
healthcare resources at all levels are being directed toward fighting the COVID-19 pandemic. While this has resulted in encouraging progress, many non-coronavirus patients are finding it difficult to access care due to limited available resources, while others avoid seeking in-person medical treatment for fear of exposure to the virus.

This trend is especially concerning among patients in need of chronic care, who account for 76% of all physician visits. For those with chronic diseases, failure to access care can lead to high-acuity care episodes, a situation that is dangerous and disruptive to patients, in addition to being costly for patients, payors, and providers alike.

To avoid these negative outcomes, and to preserve specialist availability and critical health care resources, health care organizations must find ways to provide safe access to primary care for patients with chronic conditions. One potential avenue for providing this care is through the use of eConsults and other forms of telehealth for chronic care management.

No comment yet.
Scooped by EcoVadis
June 18, 2020 3:00 PM
Scoop.it!

Ethical principles in health care prove critical to protecting health care workers in pandemic

Ethical principles in health care prove critical to protecting health care workers in pandemic | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it
Health care practitioners and professionals are central to the world’s defeat of COVID-19, as well as to our societies’ ability to recover from this global health and economic crisis. These workers require a safe work environment even when scenarios are changing rapidly, and that is why a set of ethical principles that embraces health worker safety can be so important.

No comment yet.
Scooped by EcoVadis
May 19, 2020 3:58 AM
Scoop.it!

Rediscovering sustainable development through a Covid-19 lockdown lens

Rediscovering sustainable development through a Covid-19 lockdown lens | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it
The economic shutdown under the Covid-19 pandemic has had two monumental impacts on our environment. It has improved our air and water quality dramatically, and slashed our material consumption, water usage and waste production.

Data from the CPCB (Central Pollution Control Board) and the UPPCB (Uttar Pradesh Pollution Control Board) shows that the Ganga’s water along its most polluted stretch in Uttar Pradesh is carrying more dissolved oxygen and less nitrates. These conditions are conducive to survival of aquatic life. Its biochemical oxygen demand (BOD) has correspondingly fallen, along with the concentration of total coliform, which is a testament to improved water quality. Similar positive developments have been reported for the Yamuna.
No comment yet.
Scooped by EcoVadis
July 2, 2020 8:31 AM
Scoop.it!

Patients happy with virtual care

Patients happy with virtual care | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it

A survey by medical software provider Kyruus of 1,000 adult patients found that nearly three quarters had tried virtual care during the COVID crisis and more than 75 percent were very or completely satisfied with their experience.

No comment yet.
Scooped by EcoVadis
June 22, 2020 6:15 AM
Scoop.it!

Protective Mask Recycling Offers Promise

Protective Mask Recycling Offers Promise | Sustainable Procurement & CSR News - Pharmaceutical Industry | Scoop.it
At present, all surgical and FFP2 face masks must be thrown away after a few hours of use. To offset the shortage of protective equipment, scientists, physicians and manufacturers are working together to explore ways to reuse them safely. Professor Philippe Cinquin provides an overview of the methods being tested by this consortium.
No comment yet.
Scooped by EcoVadis
May 26, 2020 1:53 AM
Scoop.it!

Coronavirus May Test Global Pharma's Economic Model

The coronavirus pandemic could test the economic model of the pharmaceutical sector if it leads to weaker patent protection, Fitch Ratings says. In our view, a balanced response, such as tiered pricing and greater collaboration between pharma companies, will be required to develop a sustainable commercial model for COVID-19 medicines.

The innovative pharma sector's approach to the pandemic is based on developing three pillars of response: testing, treatment and vaccines. Testing kits developed by various companies were urgently needed during the first stage of the outbreak to monitor the virus's spread and attempt to contain it. Testing is now becoming the key tool in transitioning into the post-lockdown phase where antibody testing, alongside contact-tracing, could help to reopen economies while containing the virus until readily accessible treatments or vaccines are available.

COVID-19 treatments and the associated approach to pricing could bring changes to the economic model of the sector. We expect scarcity of any drugs relative to vast global demand for such treatments will add a new dimension to the three traditional components of drug pricing - clinical value, system value and return on research and development (R&D).
No comment yet.